EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates



Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates



Journal of Clinical Microbiology 36(6): 1518-1529



In a survey of bloodstream infection (BSI) isolates across the continental United States, 162 Candida albicans isolates were fingerprinted with the species-specific probe Ca3 and the patterns were analyzed for relatedness with a computer-assisted system. The results demonstrate that particular BSI strains are more highly concentrated in particular geographic locales and that established BSI strains are endemic in some, but not all, hospitals in the study and undergo microevolution in hospital settings. The results, however, indicate no close genetic relationship among fluconazole-resistant BSI isolates in the collection, either from the same geographic locale or the same hospital. This study represents the first of three fingerprinting studies designed to analyze the origin, genetic relatedness, and drug resistance of Candida isolates responsible for BSI.

(PDF 0-2 workdays service: $29.90)

Accession: 003161839

Download citation: RISBibTeXText

PMID: 9620370



Related references

Stability of fluconazole resistance phenotype in clinical isolates of fluconazole-resistant Candida albicans. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 496, 1998

A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient. Microbiology and Immunology 46(5): 317-326, 2002

Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Molecular Microbiology 36(4): 856-865, 2000

Northern analysis of multidrug resistance efflux pump and target site mRNA in fluconazole-sensitive and fluconazole-resistant oropharyngeal isolates of Candida albicans collected from AIDS patients. Abstracts of the General Meeting of the American Society for Microbiology 98: 529-530, 1998

Visual reading of MIC endpoints Are we over-estimating fluconazole resistance among Candida tropicalis bloodstream isolates?. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 374, 2001

Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance. American Journal of Infection Control 38(6): 456-460, 2010

Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. Journal of Clinical Microbiology 47(6): 1927-1930, 2009

Fluconazole resistance in candida albicans isolates from patients with aids. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b128, 1992

In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. Journal of Antimicrobial ChemoTherapy 55(5): 692-698, 2005

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. Journal of Clinical Microbiology 50(4): 1199-1203, 2012

Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles. Bioorganic & Medicinal Chemistry Letters 22(9): 3362-3365, 2012

Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. Journal of Antimicrobial ChemoTherapy 47(5): 527-536, 2001

Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. International Journal of Antimicrobial Agents 27(5): 403-408, 2006

Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mycoses 59(2): 93-100, 2016

Molecular epidemiological analysis of bloodstream isolates of Candida albicans from a university hospital over a five-year period. Journal of Microbiology 43(6): 546-554, 2006